Go Summarize

a16z Podcast | On Recent Consolidation in the Healthcare Industry

a16z2019-01-02
138 views|5 years ago
💫 Short Summary

The healthcare industry is undergoing major changes with Walmart, CVS, Amazon, and other players driving consolidation and innovation to reduce costs. Challenges such as geographical dispersion and logistical issues are being addressed through vertical integration and new technologies. The future of the industry, including the potential for digital therapeutic PBMs and advancements in genomic testing, remains uncertain but promising for entrepreneurs and the healthcare sector as a whole.

✨ Highlights
📊 Transcript
Recent healthcare industry headlines indicate increased vertical integration with Walmart potentially acquiring Humana.
02:16
The industry is evolving into a single entity with key players such as insurers, pharmacies, PBMs, and wholesalers.
Aetna's merger with CVS and the collaboration between Amazon, JP Morgan, and Berkshire Hathaway are significant developments in the healthcare sector.
The main objective of these moves is to reduce costs through consolidation, but the impact on outcomes remains uncertain.
Changes in the healthcare industry are being driven by major players like Walmart and CVS emphasizing local ownership.
04:00
Amazon and Berkshire Hathaway face challenges due to their geographical dispersion, while Amazon's potential entry into the Pharmacy Benefit Manager (PBM) business could disrupt the industry further.
Entrepreneurs have opportunities to innovate and adapt to the shifting landscape in the healthcare industry.
The concept of a digital therapeutic PBM is proposed as a transformative solution to distribution and reimbursement challenges in healthcare.
The evolving healthcare industry is focused on increasing efficiencies and reducing costs.
06:08
Entrepreneurs are looking into vertical integration and new technologies to streamline processes.
Amazon and other companies are entering the healthcare sector through partnerships and hiring initiatives.
Major acquisitions like Whole Foods in the healthcare industry are not expected.
The rise of cell therapies and gene therapies is creating logistical challenges, potentially leading to a digital PBM logistics chain for advanced medicines.
Challenges in the genomic testing industry due to limited tests, expensive cell therapies, and supply chain difficulties.
08:05
Uncertainties in building a sustainable business model, different from specialty Pharma.
The future of the industry is uncertain with potential for significant changes and developments.